Federal Supply Schedule 36F79723D050E
Award Date
9/2/23
Last Date to Order
2/14/24
Federal Agency
Veterans Integrated Service Network 12
Awardee
Verrica Pharmaceuticals Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The Department of Veterans Affairs (VA) awarded a Federal Supply Schedule (FSS) contract under Schedule 65 IB to Verrica Pharmaceuticals Inc., a pharmaceutical company specializing in dermatology and hematology products. The FSS contract has a ceiling value of $225,000 and a period of performance through February 2029. This contract vehicle allows VA medical centers and other ordering activities to acquire qualified pharmaceutical, topical treatment, and hematology-related products directly...
This Blanket Purchase Agreement (BPA) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Verrica Pharmaceuticals Inc., a pharmaceutical company specializing in dermatology and hematology products. The BPA has a ceiling value of $1,250,000 and a period of performance from August 16, 2024 to August 15, 2025, for the procurement of the pharmaceutical product YCANTH.
Verrica Pharmaceuticals also holds other contract vehicles with the VA, including a Federal...
This Blanket Purchase Agreement (BPA) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Verrica Pharmaceuticals Inc., a for-profit pharmaceutical company. The single-award BPA has a ceiling value of $1,250,000 and a period of performance from September 2, 2023 to August 13, 2024.
The BPA is for the pharmaceutical product YCANTH, which Verrica Pharmaceuticals supplies to the VA through this contract vehicle as well as other Federal Supply Schedule (FSS)...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs (VA) to Verona Pharma, Inc. for the provision of pharmaceutical, hematology, and related products. The Multiple Award contract has a ceiling value of $225,000.00 and a period of performance from March 15, 2025 through March 14, 2030.
The contract is classified as 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS under the Federal Supply Schedule. As a Federal Supply Schedule, this is an...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, awarded by the Department of Veterans Affairs (VA) to Perrigo Company's Perrigo Sourcing Solutions, Inc. division. The contract has a ceiling value of $506,112,050.00 and a period of performance from October 1, 2018 to September 30, 2025.
The purpose of this contract is to provide the VA and other federal agencies with a wide range of pharmaceutical and...
The federal contract IDV award is a Federal Supply Schedule contract (FSS-61-IB) for Pharmaceuticals and Drugs, awarded by the Department of Veterans Affairs (VA) to Biofrontera Inc. The contract has a period of performance from August 15, 2018 to August 31, 2024, with a ceiling value of $451,170.00.
The contract aims to procure a range of pharmaceutical and hematology-related products for the VA's healthcare system. As a Federal Supply Schedule contract, it provides a pre-negotiated catalog...
The Department of Veterans Affairs Veterans Integrated Service Network 12 awarded a multiple-award Federal Supply Schedule contract (IDV #36F79722D047E) to Veru Inc., doing business as Veru Healthcare, for the provision of drugs, pharmaceuticals, and hematology-related products under Schedule 65 IB. The contract has a ceiling value of $25,000 and a period of performance through October 2023.
Veru Inc. is a for-profit organization and manufacturer of medical goods, including pharmaceuticals,...
The provided information describes a Federal Supply Schedule (FSS) contract awarded by the U.S. Department of Veterans Affairs (VA) to Verona Pharma, Inc. The contract, with an ID of 36F79724D053E, is for the procurement of drugs, pharmaceuticals, and hematology-related products under Schedule 65 I B. This is a multiple-award contract with a period of performance through March 14, 2025 and a ceiling value of $25,000.00.
As a Federal Supply Schedule contract, this agreement establishes...
The Department of Veterans Affairs awarded a Federal Supply Schedule contract to Vyera Pharmaceuticals, LLC to procure drugs, pharmaceuticals, and related hematology products. The potential value of this multiple award schedule is $3.5 million with an ordering period through September 2029.
Additionally, the National Acquisition Center established a single award Blanket Purchase Agreement with Vyera Pharmaceuticals on behalf of the Veterans Health Administration. Valued at $450,000, this BPA...
The key details of this federal contract IDV are as follows:
This is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the U.S. Department of Veterans Affairs. The contract was awarded to Dermavant Sciences Inc. and has a ceiling value of $500,000.00. The contract is for the provision of drugs, pharmaceuticals, and hematology-related products (FSC 65 IB) and has an ultimate completion date of January 14, 2028....